UK markets closed

Entheon Biomedical Corp. (ENTBF)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.09650.0000 (0.00%)
At close: 10:40AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/11/2022
30/11/2021
30/11/2020
31/03/2020
Cash flows from operating activities
Net income
-6,068
-8,521
-8,887
-4,381
-146.783
Depreciation & amortisation
1.089
2.095
3.838
2.724
-
Deferred income taxes
0
-
-
-
0
Stock-based compensation
36.468
85.306
2,552
0
36.468
Change in working capital
280.051
436.86
486.321
-1,198
7.988
Inventory
-
-
0.881
0
-
Other working capital
-412.061
-1,955
-5,615
-2,847
-187.317
Other non-cash items
0.01
-
-
2,736
0.01
Net cash provided by operating activities
-412.061
-1,955
-5,615
-2,838
-102.317
Cash flows from investing activities
Investments in property, plant and equipment
-85
-
-97.97
-9.033
-85
Acquisitions, net
-
-
-56.808
-
-
Purchases of investments
-
0
-405.76
-248
-
Sales/maturities of investments
550.735
633.874
21.115
185.086
-
Other investing activities
-
-25
-
-
-
Net cash used for investing activities
-85
585.643
-98.866
1,082
-85
Cash flows from financing activities
Debt repayment
-
-
0
-3.029
-
Common stock issued
0
0
3,083
4,433
0
Other financing activities
95.326
-
-
-
95.326
Net cash used provided by (used for) financing activities
95.326
0
4,976
4,430
95.326
Net change in cash
-240.992
-857.296
-570.723
2,674
-91.991
Cash at beginning of period
248.385
2,049
2,787
112.655
1,224
Cash at end of period
381.809
680.166
2,049
2,787
1,132
Free cash flow
Operating cash flow
-412.061
-1,955
-5,615
-2,838
-102.317
Capital expenditure
-85
-
-97.97
-9.033
-85
Free cash flow
-412.061
-1,955
-5,615
-2,847
-187.317